FDA grants orphan drug designation to SFX-01 for the treatment of subarachnoid haemorrhage Aug. 25, 2016
GlaxoSmithKline and Astex present a novel potent and reversible inhibitor of PAF acetylhydrolase Aug. 24, 2016
RSS